About 8,745 results

ALLMedicine™ Sarcoidosis Center

Research & Reviews  2,933 results

Peripheral neuropathy in sarcoidosis.
Journal of Neuroimmunology; Tavee J

May 19th, 2022 - Peripheral nerve disorders in sarcoidosis consist of granulomatous neuropathy and non-granulomatous small fiber neuropathy (SFN), which differ in their underlying pathology, diagnostic methods and treatment. While granulomatous nerve involvement i...

The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenge...
https://doi.org/10.1007/s40257-022-00693-0 10.1038/s41572-019-0096-x 10.1097/MCP.0000000000000402 10.1111/j.1365-2230.2011.04128.x 10.1007/s40257-014-0079-3 10.1056/NEJMra2101555 10.1093/oxfordjournals.aje.a114313 10.1177/2040622318790197 10.1016/S0954-6111(03)00127-6 10.1038/s41598-018-27554-3 10.1513/AnnalsATS.201508-568BC 10.1016/j.rmed.2014.12.012 10.1007/s40266-013-0125-5 10.1136/thoraxjnl-2016-209032 10.1183/13993003.00477-2016 10.1016/j.rmed.2021.106548 10.1513/AnnalsATS.201511-760OC 10.1055/s-2007-970331 10.1155/2014/236905 10.1183/09031936.00075307 10.1186/s12931-018-0871-3 10.1378/chest.10-0413 10.1016/j.jaad.2021.04.079 10.1016/j.ophtha.2006.05.074 10.1378/chest.14-1120 10.1016/S0002-9343(97)89518-6 10.1097/MD.0b013e3182569f91 10.1111/jdv.13760 10.1136/thx.2007.094060 10.1164/ajrccm.164.11.2106001 10.1093/aje/153.2.188 10.1183/13993003.00385-2018 10.3390/ijerph16101830 10.1165/rcmb.2014-0227OC 10.1038/s41598-019-54612-1 10.3389/fimmu.2017.00422 10.1164/rccm.201507-1344LE 10.1165/rcmb.2015-0278OC 10.3390/jcm9082633 10.1007/s10067-021-05684-w 10.3389/fimmu.2019.02964 10.1007/s00439-018-1915-y 10.1183/13993003.00430-2019 10.3389/fgene.2019.00049 10.1038/ni.3691 10.3390/cells9102184 10.1002/pro.3519 10.1097/MOH.0000000000000301 10.1038/s41598-017-04109-6 10.1002/acr2.11112 10.1016/j.jaad.2019.05.098 10.1513/AnnalsATS.201707-565OT 10.1186/s12890-016-0332-z 10.1001/archderm.141.7.909-b 10.1111/j.1600-0560.2009.01271.x 10.1001/jamadermatol.2021.1577 10.1038/nrrheum.2011.93 10.1016/j.chest.2020.12.027 10.4049/jimmunol.181.12.8784 10.1084/jem.20040429 10.1016/j.chest.2021.06.003 10.1016/S0140-6736(05)65119-7 10.1097/ACI.0b013e3283515173 10.1097/00000372-200010000-00004 10.1111/j.0303-6987.2004.00157.x 10.1055/s-0034-1377059 10.1164/rccm.200402-249OC 10.1378/chest.06-2114 10.1016/j.chest.2017.10.014 10.1515/jomb-2017-0041 10.12703/b/9-14 10.1183/09031936.98.11051015 10.7326/0003-4819-111-5-437 10.1111/1346-8138.13654 10.1007/s10067-004-0971-y 10.1007/s00296-014-3024-0 10.1378/chest.130.2.526 10.3389/fimmu.2019.02933 10.1016/j.autrev.2018.04.004 10.3389/fimmu.2018.01516 10.1097/MCP.0000000000000809 10.1016/j.jaad.2012.02.003 10.1016/S2213-2600(18)30064-X 10.1016/0091-6749(93)90352-G 10.2217/imt.14.103 10.1111/cei.12403 10.1007/s00005-015-0344-z 10.1111/j.1365-2567.2008.03017.x 10.1093/rheumatology/ker316 10.1136/thx.2010.140319 10.1186/1479-5876-12-152 10.3389/fimmu.2019.01923 10.1164/rccm.201507-1499OC 10.3390/ijms21197398 10.1164/rccm.202012-4423OC 10.1136/thx.47.11.964 10.1007/s10067-018-4183-2 10.1128/CVI.05118-11 10.1038/nri.2017.14 10.1016/j.molcel.2010.09.026 10.1038/s41556-018-0217-x 10.3390/cells8010018 10.1016/j.it.2020.01.007 10.1038/ni.3655 10.1016/j.rmed.2020.106294 10.1080/23723556.2015.1010958 10.1038/s41580-018-0003-4 10.1183/13993003.02695-2020 10.1136/thorax.58.6.519 10.1165/rcmb.2018-0053OC 10.1080/14712598.2018.1427727 10.1111/ijd.14218 10.1001/archderm.1997.03890430098013 10.1016/j.jaad.2020.10.021 10.1513/AnnalsATS.201902-119CME 10.1164/rccm.202002-0251ST 10.1016/j.mayocpiqo.2019.04.006 10.1001/jamadermatol.2015.2008 10.1001/archdermatol.2011.301 10.2165/00128071-200809030-00003 10.1001/jamadermatol.2013.4646 10.1001/jamadermatol.2013.60 10.1001/jamadermatol.2019.3519 10.1055/s-0040-1713130 10.1111/j.1346-8138.2011.01342.x 10.1111/j.1365-2230.2007.02397.x 10.4103/0378-6323.33649 10.1016/0190-9622(90)70246-E 10.2165/00003495-200868100-00003 10.1183/13993003.04079-2020 10.1016/j.jaad.2016.02.1239 10.1111/ced.14614 10.1016/j.jaad.2012.10.056 10.1001/archderm.141.7.910 10.1378/chest.08-1347 10.1111/j.1365-2230.2010.03829.x 10.1159/000221005 10.1001/jamadermatol.2017.1162 10.1093/rheumatology/kep046 10.1016/j.crohns.2012.01.008 10.1016/j.autrev.2019.102390 10.1093/rheumatology/key276 10.1016/j.jdcr.2019.02.006 10.1056/NEJMoa1805958 10.1016/j.jaad.2019.06.1297 10.1136/annrheumdis-2020-217271 10.1136/annrheumdis-2019-215387 10.1007/s00408-021-00439-5 10.1007/s00408-021-00436-8 10.1016/j.jdcr.2020.12.021 10.1016/j.jdcr.2020.11.016 10.1016/j.chest.2018.08.808 10.1111/ced.14101 10.25251/skin.1.2.7 10.1136/thoraxjnl-2013-203307 10.1038/s41598-019-50614-1 10.1046/j.1365-2249.2003.02105.x 10.4161/mabs.3.6.17815 10.1183/09031936.00000914 10.1080/09273948.2019.1569245 10.1186/s13256-019-2137-1 10.1111/bjd.13365 10.2174/1574886315666200316113312 10.1172/JCI110036 10.1186/s12948-015-0025-9 10.1177/1756286418805732 10.1212/WNL.0b013e3181ec7ff9 10.1093/rheumatology/kev309 10.1016/j.cardfail.2021.07.008 10.1183/09031936.00224513 10.1111/dth.13693 10.1684/ejd.2017.3143 10.1001/archderm.137.1.69 10.1016/j.autrev.2003.10.001 10.1183/23120541.00486-2020 10.1002/joa3.12084 10.1038/ni.3153 10.1038/s41584-020-0419-z 10.3389/fimmu.2020.631299 10.1186/s10020-018-0047-0 10.1164/rccm.200905-0696OC 10.1001/archdermatol.2011.341 10.1111/ijd.14909 10.1111/bcp.14878 10.3899/jrheum.130278 10.1111/j.1476-5381.2009.00559.x 10.1080/17512433.2021.1878024 10.1164/ajrccm.159.2.9804085 10.1378/chest.124.4.1526 10.1164/ajrccm.155.5.9154873 10.1111/j.1432-2277.2011.01256.x 10.1164/rccm.202004-0914IM 10.1136/bcr-2020-235372 10.4081/monaldi.2017.835 10.1164/rccm.200807-1082OC 10.1111/crj.12559 10.1086/378097 10.1080/09273948.2019.1705985 10.1034/j.1399-0039.2000.560107.x
American Journal of Clinical Dermatology; Wu JH, Imadojemu S et. al.

May 19th, 2022 - Sarcoidosis is a multisystem disorder of unknown etiology characterized by accumulation of granulomas in affected tissue. Cutaneous manifestations are among the most common extrapulmonary manifestations in sarcoidosis and can lead to disfiguring d...

Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic...
Radiology Aitken M, Chan MV et. al.

May 18th, 2022 - Background There is limited consensus regarding the relative diagnostic performance of cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac sarcoidosis. Purpose To perform a systematic review and meta-analysis to compare the diagnostic accurac...

Cell Free DNA in Cardiac Sarcoidosis

May 18th, 2022 - Sarcoidosis is a multisystem granulomatous disease of unknown cause that can affect any organ in the body, including the heart. Sarcoidosis results from an immune reaction to an environmental exposure to yet unknown antigen(s) in a genetically pre...

see more →

Guidelines  4 results

ERS clinical practice guidelines on treatment of sarcoidosis.
The European Respiratory Journal; Baughman RP, Valeyre D et. al.

Jun 19th, 2021 - The major reasons to treat sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL). The indication for treatment varies depending on which manifestation is the cause of symptoms: lungs, heart, brain, skin or o...

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical ...
American Journal of Respiratory and Critical Care Medicine; Crouser ED, Maier LA et. al.

Apr 16th, 2020 - Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternativ...

2019 HRS expert consensus statement on evaluation, risk stratification, and management ...
Heart Rhythm; Towbin JA, McKenna WJ et. al.

May 13th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

Consensus statement on surgical pathology of the aorta from the Society for Cardiovascu...
Cardiovascular Pathology : the Official Journal of the So... Stone JR, Bruneval P et. al.

Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...

see more →

Drugs  242 results see all →

Clinicaltrials.gov  89 results

Cell Free DNA in Cardiac Sarcoidosis

May 18th, 2022 - Sarcoidosis is a multisystem granulomatous disease of unknown cause that can affect any organ in the body, including the heart. Sarcoidosis results from an immune reaction to an environmental exposure to yet unknown antigen(s) in a genetically pre...

Endobronchial Ultrasound Transbronchial Needle Aspiration Of Enlarged Mediastinal In Interstitial Lung Disease

May 10th, 2022 - The aim of this study is to assess the findings of mediastinal/hilar LN sampling by EBUS-TBNA in patients with non-sarcoidosis interstitial lung disease ( ILD) who demonstrate LN enlargement on chest imaging. Patients with non-sarcoidosis ILD refe...

A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis

May 4th, 2022 - This is a randomized, double-blind, placebo-controlled study with an OLE. Participants will be randomized to receive namilumab or placebo in the 26-week Double-blind Treatment Period of the study. Namilumab, or placebo, will be administered subcut...

Ductal Lavage Versus Corticosteroids Therapy for Idiopathic Granulomatous Mastitis

May 2nd, 2022 - Non-lactational mastitis (NLM) consists of a broad spectrum of inflammatory breast diseases. Among them, periductal mastitis and idiopathic granulomatous mastitis(IGM) are the most commonly encountered in clinical practice. IGM can be diagnosed wh...

A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis

Apr 28th, 2022 - A Randomized, Double-blind, Placebo-controlled, Study with an Open-label Cohort. Participants enrolled in Cohort A will be randomized to receive namilumab, or placebo, and will also be treated with a daily dose of prednisone or equivalent, in addi...

see more →

News  208 results

Granuloma Faciale in Woman With Levamisole-Induced Vasculitis
Ruby Gibson, MD, Valerie Shiu, MD et. al.

Apr 26th, 2022 - To the Editor: A 53-year-old Hispanic woman presented to our dermatology clinic for evaluation of an expanding plaque on the right cheek of 2 months’ duration. The patient stated the plaque began as a pimple, which she picked with subsequent sprea.

Fast Five Quiz: Progressive Fibrosing Interstitial Lung Disease

Apr 12th, 2022 - Interstitial lung diseases (ILDs) encompass a large and varied group of parenchymal lung disorders, including diseases of unknown cause, which are known as idiopathic interstitial pneumonias, as well as those associated with other diseases or envi...

Painful swelling of fingers and toe

Mar 9th, 2022 - Although psoriatic arthritis is not the only disease associated with dactylitis — other culprits are sarcoidosis, septic arthritis, tuberculosis, and gout — dactylitis is one of the characteristic symptoms of psoriatic arthritis. Dactylitis is see.

IBD or something else? Key characteristics offer clues
Nancy A. Melville

Feb 18th, 2022 - Immune-mediated inflammatory diseases (IMIDs) of the gastrointestinal (GI) tract, with features that often mimic each other, commonly present clinical challenges. But key characteristics can help distinguish the most common – inflammatory bowel di.

Little Evidence to Support Use of Pricey Repository Corticotropin

Dec 22nd, 2021 - NEW YORK (Reuters Health) - Repository corticotropin costs much more than corticosteroids, but shows little clinical benefit over them, results of a scoping review suggest. "In this comprehensive review, we found that the clinical evidence support...

see more →

Patient Education  22 results see all →